Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Yung Zip Chemical Ind. Co., Ltd. (4102:TWSE), powered by AI.
Yung Zip Chemical Ind. Co., Ltd. is currently trading at $18.95. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Yung Zip Chemical Ind. Co., Ltd. on Alpha Lenz.
View Yung Zip Chemical Ind. Co., Ltd.'s valuation metrics on Alpha Lenz.
“Yung Zip Chemical Ind. Co., Ltd.'s ROE is -2.3%. Explore profitability and growth together.”
Ask for details →Yung Zip Chemical Ind. Co., Ltd. is a Taiwanese manufacturer specializing in active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals. Founded in 1978, the company serves a global clientele across pharmaceuticals, medical, agricultural, and industrial sectors. Yung Zip is recognized for offering comprehensive contract research and manufacturing (CRO/CMO) services, supporting drug development from early-stage chemical synthesis through full-scale, GMP-compliant production. Its robust international certifications, including approvals from the FDA (USA), MHRA (UK), and PMDA (Japan), highlight its commitment to quality and regulatory rigor. The company's product range addresses areas such as antihypertensive, antifungal, analgesic, antipyretic, and schizophrenia treatments. With a sustainable management philosophy focused on innovation, efficiency, and service, Yung Zip plays a vital role in enabling pharmaceutical supply chains and facilitating research, development, and global market access for drug companies. Its operations reflect a blend of technical expertise and consistent product quality, making it an integral participant in the health technology industry, both regionally and internationally.
“Yung Zip Chemical Ind. Co., Ltd.'s ROE is -2.3%. Explore profitability and growth together.”
Ask for details →Yung Zip Chemical Ind. Co., Ltd. (ticker: 4102) is a company listed on TWSE in the Healthcare sector (Drug Manufacturers - General). It has approximately 192 employees.
The current price is 18.95 with a P/E ratio of -x and P/B of -x.
ROE is -2.29% and operating margin is -4.18%. Annual revenue is $474M.